First in Human Study to Evaluate the Safety and Tolerability of EYP-1901 in Patients With Wet Age Related Macular Degeneration (wAMD)
Clinical trial NCT04747197 · COMPLETED
Trial details
- NCT number
- NCT04747197
- Sponsor
- EyePoint Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-20
- Primary completion
- 2022-05-11
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.